Recently Updated Pages
10 - 440 Subarachnoid Hemorrhage
440 Subarachnoid Hemorrhage occur in ~30% of cases. One-half of AVMs become evident as ICHs. In m...
09 - 439 Intracerebral Hemorrhage
439 Intracerebral Hemorrhage or symptomatic stenosis. The 30-day risk of stroke was 4.1% in the s...
08 - 438 Ischemic Stroke
438 Ischemic Stroke some centers combine both CTA and CT perfusion imaging together with the nonc...
07 - 437 Introduction to Cerebrovascular Diseases
437 Introduction to Cerebrovascular Diseases SPECIAL ISSUES RELATED TO EPILEPSY IN THE ELDERLY Ep...
06 - 436 Seizures and Epilepsy
436 Seizures and Epilepsy a second patient, the genome of the RPE cell line was sequenced, and a ...
05 - SECTION 2 Diseases of the Central Nervous System
SECTION 2 Diseases of the Central Nervous System a second patient, the genome of the RPE cell lin...
04 - 435 Pathobiology of Neurologic Diseases
435 Pathobiology of Neurologic Diseases used successfully in this setting, as has iodinated contr...
03 - 434 Neuroimaging in Neurologic Disorders
434 Neuroimaging in Neurologic Disorders tertiary care settings, multiple strokes are usually due...
02 - 433 Approach to the Patient with Neurologic Disease
433 Approach to the Patient with Neurologic Disease Section 1 Diagnosis of Neurologic Disorders ...
01 - SECTION 1 Diagnosis of Neurologic Disorders
SECTION 1 Diagnosis of Neurologic Disorders Section 1 Diagnosis of Neurologic Disorders Daniel H...
50 - 432 Inherited Defects of Membrane Transport
432 Inherited Defects of Membrane Transport Nicola Longo Inherited Defects of Membrane Transport ...
49 - 431 Inherited Disorders of Amino Acid Metabolism in Adults
431 Inherited Disorders of Amino Acid Metabolism in Adults ethnic populations, but clinical sympt...
47 - 429 Lysosomal Storage Diseases
429 Lysosomal Storage Diseases stimulates tanning, is administered subcutaneously every 2 months ...
46 - 428 The Porphyrias
428 The Porphyrias TREATMENT Wilson’s Disease COPPER CHELATION The era of successful treatment of...
45 - 427 Wilson’s Disease
427 Wilson’s Disease ■ ■ROLE OF HFE MUTATIONS IN OTHER LIVER DISEASES There is considerable inter...
44 - 426 Hemochromatosis
426 Hemochromatosis TREATMENT Marfan and Loeys-Dietz Syndromes Patients should be advised that va...
43 - 425 Heritable Disorders of Connective Tissue
425 Heritable Disorders of Connective Tissue by short bulbous roots, pulp calcification, and radi...
42 - SECTION 5 Disorders of Intermediary Metabolism
SECTION 5 Disorders of Intermediary Metabolism by short bulbous roots, pulp calcification, and ra...
41 - 424 Paget’s Disease and Other Dysplasias of Bone
424 Paget’s Disease and Other Dysplasias of Bone Osteoporosis and related fractures are serious s...
40 - 423 Osteoporosis
423 Osteoporosis supplementation is sometimes needed for weeks to a month or two until bone defec...